Infliximab Biosimilar CT-P13 for Crohn Disease Appears Effective

A large equivalence study shows similarity in efficacy and safety with the original formulation.

Source link

Related posts

Adipose cell size changes are associated with a drastic actin remodeling


Simplified treatment monitoring may be effective for certain HCV cases


Sherman Prize honors researchers for work in Crohn’s, ulcerative colitis


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy